Patents by Inventor Avital Lev

Avital Lev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immuno-molecules containing viral proteins, compositions thereof and methods of using
    Patent number: 8449889
    Abstract: An immuno-molecule which comprises a soluble human MHC class I effector domain; and an antibody targeting domain which is linked to the soluble human MHC class I effector domain, methods of making same and uses thereof.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: May 28, 2013
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yoram Reiter, Avital Lev
  • IMMUNO-MOLECULES CONTAINING VIRAL PROTEINS, COMPOSITIONS THEREOF AND METHODS OF USING
    Publication number: 20120003249
    Abstract: An immuno-molecule which comprises a soluble human MHC class I effector domain; and an antibody targeting domain which is linked to the soluble human MHC class I effector domain, methods of making same and uses thereof.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 5, 2012
    Applicants: Teva Pharmaceutical Industries Ltd., Technion Research & Development Foundation Ltd.
    Inventors: Yoram REITER, Avital Lev
  • Immuno-molecules containing viral proteins, compositions thereof and methods of using
    Patent number: 8022190
    Abstract: An immuno-molecule which comprises a soluble human MHC class I effector domain; and an antibody targeting domain which is linked to the soluble human MHC class I effector domain, methods of making same and uses thereof.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: September 20, 2011
    Assignees: Technion Research & Development Foundation Ltd., Teva Pharmaceutical Industries Ltd.
    Inventors: Yoram Reiter, Avital Lev
  • ANTI INFLUENZA ANTIBODIES AND USES THEREOF
    Publication number: 20110033473
    Abstract: Provided are antibodies comprising an antigen recognition domain capable of binding an MHC molecule being complexed with an influenza peptide wherein the antibody does not bind the MHC molecule in an absence of the complexed peptide and wherein the antibody does not bind the peptide in an absence of the MHC molecule. Also provided are methods of using same for diagnosing and treating influenza.
    Type: Application
    Filed: April 5, 2009
    Publication date: February 10, 2011
    Inventors: Yoram Reiter, Avital Lev
  • Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
    Publication number: 20050063970
    Abstract: An immuno-molecule which comprises a soluble human MHC class I effector domain; and an antibody targeting domain which is linked to the soluble human MHC class I effector domain, methods of making same and uses thereof.
    Type: Application
    Filed: June 18, 2002
    Publication date: March 24, 2005
    Inventors: Yoram Reiter, Avital Lev
  • Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
    Publication number: 20030017134
    Abstract: An immuno-molecule which comprises a soluble human MHC class I effector domain; and an antibody targeting domain which is linked to the soluble human MHC class I effector domain, methods of making same and uses thereof.
    Type: Application
    Filed: March 29, 2002
    Publication date: January 23, 2003
    Applicant: Technion Research and Development Foundation Ltd.
    Inventors: Yoram Reiter, Avital Lev